BPC-157
Body Protection Compound studied in in-vitro cytoprotection research.
Specification
- Catalogue ID: VL-001
- HPLC purity: 99.8%
- Formulation: Lyophilized
- Quantity: 10mg / Vial
- Price: £51.00
Cytoprotection · angiogenesis · cell migration
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a partial sequence of a cytoprotective protein found in human gastric juice. Its stable aqueous behaviour and ready commercial availability have made it one of the most referenced subjects in modern in-vitro cytoprotection research.
Research groups have used BPC-157 as a tool compound in studies examining nitric oxide synthase activity, vascular endothelial growth factor (VEGF) signalling, and focal-adhesion kinase (FAK)/paxillin pathway regulation — all of which are implicated in angiogenesis and directed cell migration in culture models.
The peptide is notable for its resistance to hydrolysis in acidic aqueous environments, a property that distinguishes it from many bioactive peptides and has prompted its use as a stability reference in gastrointestinal-tract in-vitro models.
No physiological or therapeutic properties are claimed; supplied strictly for in-vitro laboratory research use only.
Compound identity
- CAS number: 137525-51-0
- Molecular formula: C₆₂H₁₁₁N₁₅O₁₃
- Molecular weight: 1419.56 Da
- Sequence: GEPPPGKPADDAGLV
- Solubility: Soluble in water at ≥1 mg/mL
- Reconstitution: Add 1 mL bacteriostatic water per 5 mg; swirl gently, do not shake
- Stability once reconstituted: Reconstituted solution stable for up to 28 days at 4 °C when stored sterile
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.